1. Introduction
1.1. Executive Summary
1.2. Market Definition
1.3. The scope of the Study
2. Research Methodology
2.1. Secondary Research
2.2. Primary Research
2.3. Analytics Tools & Model
2.4. Economic Indicators
2.4.1.Base Year, Base Currency & Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
3. Market Analysis
3.1. Industry Value Chain Analysis
3.2. Porter's Five Force Analysis
3.2.1 Bargaining Power of Suppliers
3.2.2 Bargaining Power of Buyers
3.2.3 Threat of Substitutes
3.2.4 Threat of New Entrants
3.2.5 Industry Rivalry (Competitive Environment)
3.3. PESTLE Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4. SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.4.5 Y-O-Y Analysis
4. Market Dynamics
4.1. Drivers
4.1.1 Growing population worldwide.
4.1.2 Prevalence in target and chronic diseases.
4.1.3 Better government and private body initiatives.
4.2. Restraints
4.2.1 Higher costs associated with treatment modes.
4.2.2 Excise duty imposed on the sale of medical devices in mature markets.
4.3. Opportunities
4.3.1 Larger target patient pool and never-ending incomes in engineering economies.
4.4. Challenges
4.4.1 Low adoption rate of digital technology-based systems and untapped markets.
5. Global Head and Neck Cancer Diagnostics Market – By Diagnostics methods
5.1. Diagnostics imaging equipment
5.1.1 PET/CT
5.1.2 MRI
5.1.3 X-Ray
5.1.4 Barium swallow test
5.2. Endoscopy screening equipment
5.2.1 Pharyngoscopy
5.2.2 Laryngoscopy
5.2.3 Panendoscopy
5.3. Bioscopy screening tests
5.3.1 Incisional biopsy
5.3.2 Fine needle aspiration
5.3.3 Biopsy
5.3.4 HPV testing
5.4. Blood tests
5.4.1 Total cell count tests
5.4.2 Liver function test
5.4.3 EBV antibody measurement
5.5. Dental diagnostic methods
5.5.1 Fluorescence visualisation
5.5.2 Toluidine blue dye-based method
5.5.3 Acetic acid rinse method
5.5.4 Brush biopsy
6. Global Head and Neck Cancer Diagnostics Market - By Geography
6.1. Introduction
6.2. North America
6.2.1 U.S.
6.2.2 Canada
6.2.3 Mexico
6.3. Europe
6.3.1 U.K.
6.3.2 Germany
6.3.3 France
6.3.4. Italy
6.3.5 Spain
6.3.6. Rest Of Europe
6.4. APAC
6.4.1 China
6.4.2. India
6.4.3. Japan
6.4.4. South Korea
6.4.5. Australia & New Zealand
6.4.6. Rest Of APAC
6.5. South America
6.5.1 Argentina
6.5.2 Brazil
6.5.3 Others
6.6. The Middle East & Africa
6.6.1 Middle East
6.6.2. Africa
7. Global Head and Neck Cancer Diagnostics Market - Company Profiles
7.1 Phillips health care
7.2 Siemens healthcare
7.3 GE healthcare
7.4 Shimadzu corporation
7.5 Varian medical systems
7.6 Identafi
7.7 AdDent, Inc.
7.8 Velscope VX
7.9 Hitachi medical
7.10 Neusoft
7.11 Toshiba
7.12 Oran
7.13 Min x-ray
7.14 Hologic
7.15 LED medical diagnostics
7.16 Fujifilm holdings
8. Global Head and Neck Cancer Diagnostics Market - Competitive Landscape
8.1 Market Share Analysis
8.2 Strategies Adopted by top companies
8.3 Mergers, Acquisitions, Collaborations & Agreements
9. Market Insights
9.1 Industry Experts Insights
9.2 Analysts Opinions
9.3 Investment Opportunities
10. Appendix
10.1 List of figures
10.2 List of figures
